Home/Filings/4/0001214659-18-001544
4//SEC Filing

Goldfarb Robert I 4

Accession 0001214659-18-001544

CIK 0001625288other

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 2:53 PM ET

Size

9.4 KB

Accession

0001214659-18-001544

Insider Transaction Report

Form 4
Period: 2018-01-12
Goldfarb Robert I
Chief Operating Officer
Transactions
  • Exercise of In-Money

    Class A Warrants (right to buy)

    2018-01-122,4000 total
    Exercise: $0.25From: 2017-11-29Exp: 2018-01-31Common Stock (2,400 underlying)
  • Small Acquisition

    Common stock

    2018-01-12$0.25/sh+2,400$6001,026,400 total
Holdings
  • Class B Warrants (right to buy)

    Exercise: $0.38From: 2017-11-29Exp: 2018-05-07Common Stock (2,400 underlying)
    2,400
  • Class C Warrants (right to buy)

    Exercise: $0.50From: 2017-11-29Exp: 2018-07-14Common Stock (2,400 underlying)
    2,400
Footnotes (1)
  • [F1]Acquired in exchange for all of Robert Goldfarb's Class A warrants of Intiva BioPharma Inc.

Issuer

Intiva BioPharma Inc.

CIK 0001625288

Entity typeother

Related Parties

1
  • filerCIK 0001337910

Filing Metadata

Form type
4
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 2:53 PM ET
Size
9.4 KB